Logo image of BMNR

BITMINE IMMERSION TECHNOLOGI (BMNR) Stock Fundamental Analysis

NYSEARCA:BMNR - NYSE Arca - US09175A1079 - Common Stock - Currency: USD

42.35  +0.45 (+1.07%)

After market: 42.53 +0.18 (+0.43%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BMNR. BMNR was compared to 282 industry peers in the Software industry. Both the profitability and financial health of BMNR have multiple concerns. BMNR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year BMNR has reported negative net income.
In the past year BMNR has reported a negative cash flow from operations.
In the past 5 years BMNR always reported negative net income.
BMNR had a negative operating cash flow in each of the past 5 years.
BMNR Yearly Net Income VS EBIT VS OCF VS FCFBMNR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

BMNR's Return On Assets of -87.46% is on the low side compared to the rest of the industry. BMNR is outperformed by 89.36% of its industry peers.
With a Return On Equity value of -229.93%, BMNR is not doing good in the industry: 82.27% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -87.46%
ROE -229.93%
ROIC N/A
ROA(3y)-33.47%
ROA(5y)-41.7%
ROE(3y)-49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BMNR Yearly ROA, ROE, ROICBMNR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

BMNR has a Gross Margin of 16.39%. This is amonst the worse of the industry: BMNR underperforms 83.69% of its industry peers.
The Profit Margin and Operating Margin are not available for BMNR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BMNR Yearly Profit, Operating, Gross MarginsBMNR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

2

2. Health

2.1 Basic Checks

BMNR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BMNR has been increased compared to 1 year ago.
The debt/assets ratio for BMNR is higher compared to a year ago.
BMNR Yearly Shares OutstandingBMNR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
BMNR Yearly Total Debt VS Total AssetsBMNR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

An Altman-Z score of 31.83 indicates that BMNR is not in any danger for bankruptcy at the moment.
BMNR's Altman-Z score of 31.83 is amongst the best of the industry. BMNR outperforms 96.10% of its industry peers.
BMNR has a Debt/Equity ratio of 0.90. This is a neutral value indicating BMNR is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.90, BMNR is doing worse than 71.28% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Altman-Z 31.83
ROIC/WACCN/A
WACC10.78%
BMNR Yearly LT Debt VS Equity VS FCFBMNR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

A Current Ratio of 0.25 indicates that BMNR may have some problems paying its short term obligations.
BMNR has a worse Current ratio (0.25) than 95.39% of its industry peers.
A Quick Ratio of 0.25 indicates that BMNR may have some problems paying its short term obligations.
The Quick ratio of BMNR (0.25) is worse than 95.04% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.25
BMNR Yearly Current Assets VS Current LiabilitesBMNR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M

1

3. Growth

3.1 Past

The earnings per share for BMNR have decreased strongly by -100.71% in the last year.
Looking at the last year, BMNR shows a very strong growth in Revenue. The Revenue has grown by 158.36%.
EPS 1Y (TTM)-100.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-61.11%
Revenue 1Y (TTM)158.36%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%70.19%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BMNR Yearly Revenue VS EstimatesBMNR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 1M 2M 3M

0

4. Valuation

4.1 Price/Earnings Ratio

BMNR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BMNR Price Earnings VS Forward Price EarningsBMNR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BMNR Per share dataBMNR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BMNR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BITMINE IMMERSION TECHNOLOGI

NYSEARCA:BMNR (7/18/2025, 8:04:04 PM)

After market: 42.53 +0.18 (+0.43%)

42.35

+0.45 (+1.07%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners13.75%
Ins Owner Change7.37%
Market Cap275.27M
AnalystsN/A
Price TargetN/A
Short Float %0.23%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 59.51
P/FCF N/A
P/OCF N/A
P/B 96.48
P/tB 96.48
EV/EBITDA N/A
EPS(TTM)-2.81
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.71
BVpS0.44
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -87.46%
ROE -229.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.39%
FCFM N/A
ROA(3y)-33.47%
ROA(5y)-41.7%
ROE(3y)-49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.43%
Cap/Sales 0.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.25
Altman-Z 31.83
F-Score3
WACC10.78%
ROIC/WACCN/A
Cap/Depr(3y)65716%
Cap/Depr(5y)N/A
Cap/Sales(3y)508.37%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-61.11%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)158.36%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%70.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y97.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y95.32%
OCF growth 3YN/A
OCF growth 5YN/A